Cargando…
First-In-Human Phase 1 Clinical Trials – A Single-Center Experience In The Era Of Modern Oncotherapeutics
In the era of precision medicine the treatment options for cancer patients and subsequent outcomes are expected to improve. We present a review of patients enrolled in first-in-human Phase1 trials at University of Alabama at Birmingham. Between 1/2015–6/2017, 162 cancer patients (whole cohort, WC) w...
Autores principales: | Paluri, Ravi K., Li, Peng, Anderson, Ashley, Nandagopal, Lakshminarayana, McArdle, Traci, Young, Matthew, Robert, Franscisco, Naik, Gurudatta, Saleh, Mansoor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220914/ https://www.ncbi.nlm.nih.gov/pubmed/32404970 http://dx.doi.org/10.1038/s41598-020-64906-4 |
Ejemplares similares
-
Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma
por: Park, Robin, et al.
Publicado: (2020) -
Oncotherapeutic Strategies in Early Onset Colorectal Cancer
por: O’Reilly, Mary, et al.
Publicado: (2023) -
Oncotherapeutic Protein Kinase Inhibitors Associated With Pro-Arrhythmic Liability
por: Ye, Johan Z., et al.
Publicado: (2021) -
Alpha-Enolase: Emerging Tumor-Associated Antigen, Cancer Biomarker, and Oncotherapeutic Target
por: Almaguel, Frankis A., et al.
Publicado: (2021) -
Oncopreventive and oncotherapeutic potential of licorice triterpenoid compound glycyrrhizin and its derivatives: Molecular insights
por: Jain, Rifika, et al.
Publicado: (2022)